![Othon Gervasio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Othon Gervasio is currently working as the Chief Medical Officer at Clarity Pharmaceuticals Ltd. He previously worked as the Medical Director at Novartis Pharmaceuticals Australia Pty Ltd.
Actieve functies van Othon Gervasio
| Bedrijven | Functie | Begin |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Hoofd Techniek/Wetenschap/O&O | 26-08-2024 |
Eerdere bekende functies van Othon Gervasio
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Health Technology |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
